| Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa W Jaoko, FN Nakwagala, O Anzala, GO Manyonyi, J Birungi, A Nanvubya, ... Vaccine 26 (22), 2788-2795, 2008 | 106 | 2008 |
| Emergence of Clinical Clostridioides difficile Isolates With Decreased Susceptibility to Vancomycin C Darkoh, K Keita, C Odo, M Oyaro, EL Brown, CA Arias, BM Hanson, ... Clinical Infectious Diseases 74 (1), 120-126, 2022 | 37 | 2022 |
| Reasons for ineligibility in phase 1 and 2A HIV vaccine clinical trials at Kenya AIDS vaccine initiative (KAVI), Kenya GS Omosa-Manyonyi, W Jaoko, O Anzala, H Ogutu, S Wakasiaka, ... PloS one 6 (1), e14580, 2011 | 31 | 2011 |
| Etiology and pathogenicity of bacterial isolates: a cross sectional study among diarrheal children below five years in central regions of Kenya OW Mbuthia, SG Mathenge, MO Oyaro, MO Ng'ayo Pan African Medical Journal 31 (1), 2018 | 26 | 2018 |
| Human immunodeficiency virus infection predictors and genetic diversity of hepatitis B virus and hepatitis C virus co-infections among drug users in three major Kenyan cities M Oyaro, J Wylie, CY Chen, RO Ondondo, A Kramvis Southern African journal of HIV medicine 19 (1), 2018 | 25 | 2018 |
| Prevalence of Clostridium difficile infections among Kenyan children with diarrhea K Plants-Paris, D Bishoff, MO Oyaro, B Mwinyi, C Chappell, A Kituyi, ... International Journal of Infectious Diseases 81, 66-72, 2019 | 24 | 2019 |
| Complex Subtype Diversity of HIV-1 Among Drug Users in Major Kenyan Cities K Gounder, M Oyaro, N Padayachi, TM Zulu, T de Oliveira, J Wylie, ... AIDS research and human retroviruses 33 (5), 500-510, 2017 | 22 | 2017 |
| High rate of Clostridium difficile among young adults presenting with diarrhea at two hospitals in Kenya MO Oyaro, K Plants-Paris, D Bishoff, P Malonza, CS Gontier, HL DuPont, ... International Journal of Infectious Diseases 74, 24-28, 2018 | 19 | 2018 |
| Molecular characterization of HIV type 1 among HIV-infected respondents in a cohort being prepared for HIV Phase III vaccine clinical trials, Western Kenya M Oyaro, J Mbithi, F Oyugi, A Laten, O Anzala, S Engelbrecht AIDS research and human retroviruses 27 (3), 257-264, 2011 | 14 | 2011 |
| Analysis of fish commonly sold in local supermarkets reveals the presence of pathogenic and multidrug-resistant bacterial communities A Okyere, D Bishoff, MO Oyaro, NJ Ajami, C Darkoh Microbiology Insights 11, 1178636118786925, 2018 | 8 | 2018 |
| Safety and immunogenicity of DNA and MVA HIVA vaccines in Phase-1 vaccine trials in Nairobi, Kenya WG Jaoko, G Omosa, K Bhatt, L Matu, H Ogutu, S Wakasiaka, J Odada, ... University of Nairobi, 2004 | 8 | 2004 |
| BRCA1 and BRCA2 mutations and their clinical relevance in selected women diagnosed with triple-negative breast cancer in Kenya: a descriptive cross-sectional study JN Rioki, L Muchiri, M Mweu, J Nyagol, E Songok, J Mwangi, M Oyaro, ... Pan African Medical Journal 45 (1), 2023 | | 2023 |
| Reply to Lutgring et al C Darkoh, HL DuPont, CA Arias, M Oyaro, EL Brown, BM Hanson Clinical Infectious Diseases 75 (9), 1678-1679, 2022 | | 2022 |
| High rate of Clostridium difficile among young adults presenting with diarrhea at two hospitals in Kenya. CS Gontier, D Bishoff, HL DuPont, MO Oyaro, K Plants-Paris, P Malonza, ... University of Nairobi, 2018 | | 2018 |
| Reasons for Ineligibility in phase 1 and 2A HIV Vaccine Initiative (KAVI), Kenya GS Omosa-Manyonyi, WJ Omu Anzala, H Ogutu, S Wakasiaka, R Malogo, ... | | 2011 |
| Abstracts from AIDS Vaccine 2010 Atlanta, Georgia, USA 28 September–1 October, 2010 JI Mullins, GN Pavlakis, BK Felber, C Brander, S Le Gall, D Weiner, ... AIDS Research and Human Retroviruses 26 (10), A-1-A-184, 2010 | | 2010 |
| Molecular diversity of HIV-1 and prevalence of hepatitis B and C viruses among HIV-infected patients from selected districts in western Kenya MO Oyaro, JN Mbithi, AO Anzala, S Engelbrecht, L Annette University of Nairobi, 2010 | | 2010 |
| HIV-1 Molecular Subtypes and Hepatitis Viral Co-infections in a Cohort being Prepared for HIV Clinical Trials, Western Kenya MO Oyaro, JM Mbithi, AO Anzala, S Engelbrecht, F Oyugi AIDS RESEARCH AND HUMAN RETROVIRUSES 24, 160-161, 2008 | | 2008 |
| Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa FN Nakwagala, O Anzala, GO Manyonyi, J Birungi, A Nanvubya, F Bashir, ... | | 2008 |
| Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa G Jaoko Walter, FN Nakwagala, O Anzala, GO Manyonyi, J Birungi, ... | | 2008 |
